Unleash your potential with Priman: Tailored solutions for the modern man

Explore cutting-edge solutions crafted for men’s distinctive wellness needs. 

main banner img

Join our community

Group 100
check
priman home

Start your personalised wellness journey with Priman in
3 easy steps

Complete a confidential assessment

Answer a few questions about your health goals and concerns from the comfort of your home.

Connect with our licensed healthcare professionals

Our team will review your information to understand your unique needs.

Receive a personalised treatment plan

Receive a personalised plan tailored specifically for you, designed to help you achieve your wellness goals.

Easy access to our clinicians

Seamlessly reach out to our clinicians for personalised assistance and advice.

Avatars
Easy access to our clinicians

Priman Weight Loss Program: An evidence based approach

Evidence-based approach: Our program utilises proven scientific advancements, including GLP-1 and GIP medicines, to help you manage weight effectively.
Sustainable results: We focus on long-term weight management, helping you develop healthy habits for a healthier you.

Start your Weight Loss Journey:
Up to 20% Body Weight Reduction in a year**

Infographic chart

With GLP-1 Medication

Diet & Exercise alone

Wilding, J.P.H. et al. (2021) ‘Once-weekly semaglutide in adults with overweight or obesity’, New England Journal of Medicine, 384(11), pp. 989–1002. doi:10.1056/nejmoa2032183.

Meet our team

Karolina Grabowska team

Dr. Asad Raffi

Medical Advisor

Joe Biden

Alan

Pharmacist

Selena Gomez

Mohbeen

Pharmacist

Alex Smith

Dr. Abs Settipali

Health Expert

TESTIMONIALS

Real Stories, Real Results:
Hear from Our Satisfied Customers

Latest reviews

Discover Insights and Tips:
Explore our Blog

References

*Jastreboff, A. M. et al. (2022) “Tirzepatide once weekly for the treatment of obesity,” The New England journal of medicine, 387(3), pp. 205–216. doi: 10.1056/nejmoa2206038.

*Wilding, J. P. H. et al. (2021) “Once-weekly semaglutide in adults with overweight or obesity,” The New England journal of medicine, 384(11), pp. 989–1002. doi: 10.1056/nejmoa2032183.